These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26892514)

  • 1. The impact of an inverse correlation between plasma B-type natriuretic peptide levels and insulin resistance on the diabetic condition in patients with heart failure.
    Inoue Y; Kawai M; Minai K; Ogawa K; Nagoshi T; Ogawa T; Yoshimura M
    Metabolism; 2016 Mar; 65(3):38-47. PubMed ID: 26892514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
    Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.
    Maeda K; Tsutamoto T; Wada A; Hisanaga T; Kinoshita M
    Am Heart J; 1998 May; 135(5 Pt 1):825-32. PubMed ID: 9588412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BNP in overweight and obese patients with heart failure: an analysis based on the BNP-LV diastolic wall stress relationship.
    Iwanaga Y; Kihara Y; Niizuma S; Noguchi T; Nonogi H; Kita T; Goto Y
    J Card Fail; 2007 Oct; 13(8):663-7. PubMed ID: 17923359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac production of B-type natriuretic peptide is inversely related to the plasma level of free fatty acids in obese individuals - possible involvement of the insulin resistance -.
    Mizuno Y; Harada E; Katoh D; Kashiwagi Y; Morikawa Y; Nakagawa H; Yoshimura M; Saito Y; Yasue H
    Endocr J; 2013; 60(1):87-95. PubMed ID: 23006812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin A1c predicts heart failure hospitalization independent of baseline cardiac function or B-type natriuretic peptide level.
    Kishimoto I; Makino H; Ohata Y; Tamanaha T; Tochiya M; Kada A; Ishihara M; Anzai T; Shimizu W; Yasuda S; Ogawa H
    Diabetes Res Clin Pract; 2014 May; 104(2):257-65. PubMed ID: 24629410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between plasma B-type natriuretic peptide and anaemia in heart failure with or without ischaemic heart disease: a retrospective study.
    Tominaga M; Kawai M; Minai K; Ogawa K; Inoue Y; Morimoto S; Tanaka T; Nagoshi T; Ogawa T; Yoshimura M
    BMJ Open; 2019 Mar; 9(3):e024194. PubMed ID: 30837249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased plasma ELABELA level as a novel screening indicator for heart failure: a cohort and observational study.
    Liu C; Xiong J; Yi X; Song S; Yang H; Tan W; Yang X; Zheng L; Yu J; Xu C
    Sci Rep; 2024 May; 14(1):11333. PubMed ID: 38760403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between microvascular dysfunction and B-type natriuretic peptide levels in non-ischemic heart failure patients with cardiac fibrosis.
    Hirakawa K; Yamamuro M; Uemura T; Takashio S; Kaikita K; Utsunomiya D; Nakayama M; Yamamoto E; Yamashita Y; Hokimoto S; Tsujita K
    Int J Cardiol; 2017 Feb; 228():881-885. PubMed ID: 27889555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction.
    Selvaraj S; Klein I; Danzi S; Akhter N; Bonow RO; Shah SJ
    Am J Cardiol; 2012 Jul; 110(2):234-9. PubMed ID: 22502900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide levels in obese patients with advanced heart failure.
    Horwich TB; Hamilton MA; Fonarow GC
    J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of brain-derived neurotrophic factor levels in patients with heart failure and reduced left ventricular ejection fraction.
    Barman HA; Şahin I; Atıcı A; Durmaz E; Yurtseven E; Ikitimur B; Okuyan E; Keleş I
    Anatol J Cardiol; 2019 Nov; 22(6):309-316. PubMed ID: 31789613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher hemoglobin A1c levels are associated with impaired left ventricular diastolic function and higher incidence of adverse cardiac events in patients with nonischemic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Fujita T; Iida Y; Kaida T; Nabeta T; Ishii S; Maekawa E; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2017 Apr; 32(4):446-457. PubMed ID: 27672077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
    Khalid U; Wruck LM; Quibrera PM; Bozkurt B; Nambi V; Virani SS; Jneid H; Agarwal S; Chang PP; Loehr L; Basra SS; Rosamond W; Ballantyne CM; Deswal A
    Int J Cardiol; 2017 Apr; 233():61-66. PubMed ID: 28185703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide response and reverse left ventricular remodeling after surgical correction of functional mitral regurgitation in patients with advanced cardiomyopathy.
    Kainuma S; Taniguchi K; Toda K; Shudo Y; Takeda K; Funatsu T; Miyagawa S; Kondoh H; Nishi H; Yoshikawa Y; Fukushima S; Hamada S; Kubo K; Daimon T; Sawa Y
    J Cardiol; 2015 Oct; 66(4):279-85. PubMed ID: 25851471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
    Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
    Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure.
    Takashio S; Yamamuro M; Izumiya Y; Sugiyama S; Kojima S; Yamamoto E; Tsujita K; Tanaka T; Tayama S; Kaikita K; Hokimoto S; Ogawa H
    J Am Coll Cardiol; 2013 Aug; 62(7):632-40. PubMed ID: 23644085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low triiodothyronine levels correlate with high B-type natriuretic peptide levels in patients with heart failure.
    Takahashi H; Kashiwagi Y; Nagoshi T; Tanaka Y; Oi Y; Kimura H; Minai K; Yoshimura M
    Sci Rep; 2021 Nov; 11(1):21865. PubMed ID: 34750462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower B-type natriuretic peptide levels predict left ventricular concentric remodelling and insulin resistance.
    Okamoto C; Tsukamoto O; Hasegawa T; Hitsumoto T; Matsuoka K; Takashima S; Amaki M; Kanzaki H; Izumi C; Ito S; Kitakaze M
    ESC Heart Fail; 2022 Feb; 9(1):636-647. PubMed ID: 34786876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.